Results 111 to 120 of about 32,295 (302)

Electroconvulsive therapy for treatment-resistant schizophrenia [PDF]

open access: yes, 2015
This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to assess the effects (benefits and harms) of ECT for people with treatment-resistant schizophrenia.
Adams, Clive E., Sinclair, Diarmid J. M.
core   +1 more source

Regional and local divergence in welfare provision in England and Wales, 1776–1815

open access: yesThe Economic History Review, EarlyView.
Abstract This article uses the township‐level data on welfare expenditure and provision gathered by parish officers in England and Wales at three points between 1776 and 1815 to illuminate regional and local differences during the period. These data have been linked to geographic information system (GIS) mapping systems, facilitating the mapping of ...
John Broad
wiley   +1 more source

Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia [PDF]

open access: yes, 2016
The prevalence of treatment-resistant schizophrenia points to a discrete illness subtype, but to date its pathophysiologic characteristics are undetermined. Information transfer from ventral to dorsal striatum depends on both striato-cortico-striatal and
Shergill, Sukhwinder S   +11 more
core   +1 more source

A new branch of mammalian vitamin B6 metabolism: AKR1C‐mediated conversion of pyridoxal to pyridoxine and 4‐pyridoxolactone

open access: yesThe FEBS Journal, EarlyView.
Pyridoxal 5′‐phosphate (PLP) homeostasis relies on salvage enzymes, yet key metabolic branches remain undefined. We identify AKR1C isozymes as previously undescribed contributors that convert pyridoxal into pyridoxine or 4‐pyridoxolactone through reductase and dehydrogenase activities.
Nayu Kito   +8 more
wiley   +1 more source

Negative symptoms in treatment-resistant schizophrenia and its relationship with functioning [PDF]

open access: yes
Background Recent operational criteria for treatment-resistant schizophrenia (TRS) recognized positive and negative symptoms. TRS patients may have heterogeneity in negative symptoms, but empirical data were lacking. We aimed to characterize TRS patients
Leung, PBM   +11 more
core   +2 more sources

Efficacy of modified electroconvulsive therapy as augmentation agent in treatment-resistant schizophrenia

open access: yesIndian Journal of Health Sciences and Biomedical Research KLEU
AIM: The aim of the study was to study the efficacy of modified electroconvulsive therapy (MECT) as an augmentation agent in schizophrenia, with particular emphasis in treatment-resistant schizophrenia.
Chitrakshee Singh   +3 more
doaj   +1 more source

A Patient with Resistant Schizophrenia [PDF]

open access: yesBritish Journal of Psychiatry, 1987
John Gunn   +4 more
openaire   +2 more sources

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics

open access: yes, 2016
John Lally,1–3 Fiona Gaughran,1,3 Philip Timms,4,5 Sarah R Curran5–7 1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 2Department of Psychiatry, Royal College of ...
Timms P, Lally J, Gaughran F, Curran SR
core  

The impact of beliefs about mental health problems and coping on outcome in schizophrenia. [PDF]

open access: yes, 2004
Background. Using the theoretical framework of the Self Regulation Model (SRM), many studies have demonstrated that beliefs individuals hold about their physical health problems are important in predicting health outcomes.
Jones, Steven H.   +4 more
core   +1 more source

Holistic approach to substance‐induced psychosis

open access: yes
Addiction, EarlyView.
Julia M. Lappin   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy